Dilemmas in the Choice of Adequate Therapeutic Treatment in Patients with Acute Pulmonary Embolism-From Modern Recommendations to Clinical Application.

Pharmaceuticals (Basel) · 2022 · PMC9501350 · PMID 36145366

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

The authors found a similar efficacy of NOACs (recurrent VTE OR 1.07; 0.93–1.23) and a nonsignificant trend toward a reduced risk of major bleeding (OR 0.80; 0.54–1.17) [ 167 ].

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.